Evidence map›Paper›PMID 21889352›Full record

ArticleStructure (London, England : 1993)2011

Ligand-dependent perturbation of the conformational ensemble for the GPCR β2 adrenergic receptor revealed by HDX.

Graham M West, Ellen Y T Chien, Vsevolod Katritch, Jovylyn Gatchalian, Michael J Chalmers, Raymond C Stevens, Patrick R Griffin

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Structure (London, England : 1993), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 1 synthesis or guideline pooled it, 141 citations in OpenAlex.

  1. Pooled it
  2. Agonist-specific conformational dynamics at the βBritish journal of pharmacology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Conformational dynamics underlying atypical chemokine receptor 3 activation.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Article
  9. Identification of a β-arrestin-biased negative allosteric modulator for the βProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Capturing Peptide-GPCR Interactions and Their Dynamics.Molecules (Basel, Switzerland) · 2020
    Review
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Graham M WestDepartment of Molecular Therapeutics, The Scripps Research Institute, Scripps Florida, Jupiter, FL 33458, USA.
Ellen Y T Chien
Vsevolod Katritch
Jovylyn Gatchalian
Michael J Chalmers
Raymond C Stevens
Patrick R Griffin
Scripps Research Institute · USUniversity of California, San Diego · US

Funding

UHTS Implementation(Florida)U54MH084512 · NIMH · SCRIPPS RESEARCH INSTITUTE, THE · PI HODDER, PETER SIMMONS · 2008 to 2013
$89.2M
Project 3U54GM094618 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI STEVENS, RAYMOND C · 2010 to 2014
$17.1M
Scripps Research Institute Molecular Screen Center(RMI)U54MH074404 · NIMH · SCRIPPS RESEARCH INSTITUTE, THE · PI ROSEN, HUGH · 2005 to 2007
$11.6M
Development of H/D exchange technology for the study of large protein complexesR01GM084041 · NIGMS · SCRIPPS FLORIDA · PI GRIFFIN, PATRICK ROBERT · 2009 to 2012
$1.6M
Acquisition of a LTQ/Orbitrap MS to advance the study of protein dynamicsS10RR027270 · NCRR · SCRIPPS RESEARCH INSTITUTE, THE · PI GRIFFIN, PATRICK ROBERT · 2010 to 2010
$500k
NCRR NIH HHS S10 RR027270NIGMS NIH HHS R01 GM084041NIGMS NIH HHS R01-GM084041NIGMS NIH HHS U54 GM094618NIGMS NIH HHS U54-GM094618NIMH NIH HHS U54-MH074404NIMH NIH HHS U54 MH084512
6 · The paper itself

Abstract

Mechanism of G protein-coupled receptor (GPCR) activation and their modulation by functionally distinct ligands remains elusive. Using the technique of amide hydrogen/deuterium exchange coupled with mass spectrometry, we examined the ligand-induced changes in conformational states and stability within the beta-2-adrenergic receptor (β(2)AR). Differential HDX reveals ligand-specific alterations in the energy landscape of the receptor's conformational ensemble. The inverse agonists timolol and carazolol were found to be most stabilizing even compared with the antagonist alprenolol, notably in intracellular regions where G proteins are proposed to bind, while the agonist isoproterenol induced the largest degree of conformational mobility. The partial agonist clenbuterol displayed conformational effects found in both the inverse agonists and the agonist. This study highlights the regional plasticity of the receptor and characterizes unique conformations spanning the entire receptor sequence stabilized by functionally selective ligands, all of which differ from the profile for the apo receptor.

Indexed as

Protein Structure, TertiaryAdrenergic beta-2 Receptor AgonistsAdrenergic beta-2 Receptor AntagonistsAlprenololBinding SitesClenbuterolDeuterium Exchange MeasurementHumansHydrogen BondingLigandsMass SpectrometryMembranesPeptidesPropanolaminesProtein BindingProtein StabilityADRB2 protein, humanAdrenergic beta-2 Receptor AgonistsAdrenergic beta-2 Receptor AntagonistsAlprenololcarazololClenbuterolLigandsPeptidesPropanolaminesReceptors, Adrenergic, beta-2Timolol

Identifiers

PMID21889352
PMCPMC3196059
OpenAlexW1987092713

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.